KRAS and cancer: For instance, among KRAS mutation predominant cancers, KRAS-G12C mutations mainly occur in lung cancer (45%), whereas KRAS-G12D mutations are related to more than 50% of pancreatic ductal adenocarcinoma cases [40,41,42].